We next explored whether CNOT3 expression correlates with the response of lung cancer cells to gefitinib via consulting a cancer microarray database called Oncomine, and noticed the expression levels of CNOT3 mRNA in gefitinib-resistant cell lines were higher than that in gefitinib-sensitive cell lines (Fig. 5G, H). This evidence concerns the gene CNOT3 and cancer.